Eicosapentaenoic acid (all cis-5,8,11,14,17)

Eicosapentaenoic acid (all cis-5,8,11,14,17)

10417-94-4

natural

C₂₀H₃₀O₂

302

25mg

liquid

99% GC, TLC

EPA; omega-3 Fatty acid; C20:5 (all cis-5,8,11,14,17) Fatty acid [Anti-hyperlipoproteinenic agent; 5-LOX inhibitor]

chloroform, hexane, ethyl ether, ethanol, DMSO, DMF

-20°C

1. C. Song, S. Zhao “Omega-3 fatty acid eicosapentaenoic acid. A new treatment for psychiatric and neurodegenerative diseases: a review of clinical investigations.” Expert Opin Investig Drugs, Vol. 16(10) pp. 1627-1638, 2007
2. Masahiro Murata “Dual Action of Eicosapentaenoic Acid in Hepatoma Cells UP-REGULATION OF metaBOLIC ACTION OF INSULIN AND INHIBITION OF CELL PROLIFERATION” Journal of Biological Chemistry, Vol. 276 pp. 31422-31428, 2001
3. Jason D. Morrow “Formation of Highly Reactive Cyclopentenone Isoprostane Compounds (A3/J3-Isoprostanes) in Vivo from Eicosapentaenoic Acid” Journal of Biological Chemistry, Vol. 283 pp. 12043-12055, 2008